Stoke Therapeutics, Inc. (STOK)

Stoke Therapeutics Revenue

In the year 2025, Stoke Therapeutics had annual revenue of $184.42M with 404.50% growth. Stoke Therapeutics had revenue of $1.40M in the quarter ending December 31, 2025, a decrease of -93.80%.

• Revenue (ttm): $184.42M
• Revenue Growth: +404.50%
• P/S Ratio: 11.20
• Revenue / Employee: $1,084,824
• Employees: 170
• Market Cap: 2.07B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	184.42M	147.87M	404.50%
Dec 31, 2024	36.56M	27.78M	316.34%
Dec 31, 2023	8.78M	-3.63M	-29.22%
Dec 31, 2022	12.41M	-	-
Dec 31, 2021	-	-	-